26 results
8-K
EX-1.1
ORGS
Orgenesis Inc
11 Apr 24
Entry into a Material Definitive Agreement
4:20pm
of such OMPUL or services (as applicable), less:
(i) allowances or credits for damaged, rejected, or returned OMPULs, shipping costs, packaging
8-K
EX-10.1
ORGS
Orgenesis Inc
7 Mar 24
Orgenesis Inc. Announces $2.3 Million Private Placement
12:11pm
for the ownership, testing, development, manufacture, packaging, processing, use, labeling, storage, or disposal of any product manufactured by or on behalf
8-K
EX-10.1
ORGS
Orgenesis Inc
8 Nov 23
Orgenesis Inc. Announces Pricing of $1.1 Million Registered Direct Offering
9:24am
, or approval of, the uses of, the distribution of, the manufacturing or packaging of, the testing of, the sale of, or the labeling and promotion of any
8-K
EX-10.1
tefgsi4a
1 Sep 23
Entry into a Material Definitive Agreement
6:04am
8-K
EX-10.1
6wkeh1y
5 Apr 22
Orgenesis Inc. Announces $14.8 Million Private Placement
5:10pm
8-K
EX-2.1
vhwk59jef 922d56
1 Oct 20
Orgenesis Announces Agreement to Acquire Koligo Therapeutics, a Leader in Personalized Cell Therapies
5:04pm
8-K
EX-10.1
xvdxup vehl17
13 Apr 20
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-2.1
z94lqks26121 tjcz
3 Feb 20
Entry into a Material Definitive Agreement
3:16pm
8-K
EX-10.1
q7sgm0a3 ln3l1
22 Jan 20
Orgenesis Inc. Announces $9.2 Million Private Placement
12:00am